High-Grade Bond Market Kicks Off Busy Sales Day
US blue-chip companies unleashed a wave of bond sales on Monday as borrowers look to sell new debt
2023-10-31 03:54
Bristol Myers to Buy Mirati Therapeutics for $4.8 Billion
Bristol-Myers Squibb Co. has agreed to buy cancer drugmaker Mirati Therapeutics Inc. for $4.8 billion as the company
2023-10-09 09:16
Sanofi to Explore Acquisition of Cancer Drugmaker Mirati
French pharmaceutical giant Sanofi is exploring a potential acquisition of cancer drugmaker Mirati Therapeutics Inc., according to people
2023-10-06 03:26